# Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma

> **NCT01020812** · PHASE1,PHASE2 · TERMINATED · sponsor: **Stanford University** · enrollment: 11 (actual)

## Conditions studied

- Carcinoma, Hepatocellular
- Hepatobiliary Neoplasm
- Liver Carcinoma

## Interventions

- **PROCEDURE:** TACE
- **PROCEDURE:** SBRT

## Key facts

- **NCT ID:** NCT01020812
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** enrollment was too low
- **Last updated:** 2016-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020812, "Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01020812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*